BioCrowd
BioCrowd is a San Francisco-based SaaS platform founded in 2022 that connects research institutions (R1/R2 universities, hospitals, patient communities) with donors, venture philanthropists, and accredited investors for milestone-based, IRB-approved clinical research funding.
- Company typePrivate
- Founded2022
- HeadquartersSan Francisco, United States
- Headcount1–10
- GTM typeB2B and B2C
- OfferingSoftware
What BioCrowd does
BioCrowd is a San Francisco-based private biotech firm founded in 2022 that operates an institutional research funding SaaS platform connecting hospitals, universities, and patient communities with donors, venture philanthropists, and impact investors. The platform addresses capital gaps created by NIH funding uncertainty by enabling milestone-based capital raising, with funds released only after IRB-approved milestones. It targets R1 and R2 universities, academic medical centers, hospital health systems, and patient advocacy groups as primary customers, alongside accredited investors on the supply side.
The platform comprises three core products: the BioCrowd Platform acting as the capital marketplace and infrastructure layer; the Research Institution Portal for academic and hospital researchers to raise capital, manage project submissions, track milestones with blockchain verification, collaborate with research teams, and access compliance and funding analytics; and the Donor & Investor Portal that enables accredited investors and donors to discover opportunities, manage portfolios, receive real-time milestone updates, assess risk, and measure scientific and social impact. The underlying technology stack includes blockchain-verified milestone tracking, AI-powered project matching, and integration with existing Clinical Trial Management Systems (CTMS) and ERP systems to tie financial rails to institutional research workflows.
BioCrowd employs a sales-led go-to-market targeting enterprise research institutions while enabling self-serve onboarding for donors and accredited investors. Revenue mechanics are not publicly disclosed but are structured around SaaS subscriptions for institutional clients, investment facilitation fees on SAFE-Note and SPV structures, and marketplace commissions connecting capital sources with research-driven spinouts. Pricing is quote-based with annual billing, and no tiers are publicly listed. The company has showcased six featured research projects totaling $4.42M across cancer, neurology, immunology, rare diseases, and longevity, and maintains a minor partnership with NASA ISS for space-related research funding.
BioCrowd firmographics
Firmographics- Name
- BioCrowd
- Legal name
- BioCrowd
- Website
- https://biocrowd.io
- Company type
- Private
- Founded year
- 2022
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- BioCrowd is a San Francisco-based SaaS platform founded in 2022 that connects research institutions (R1/R2 universities, hospitals, patient communities) with donors, venture philanthropists, and accredited investors for milestone-based, IRB-approved clinical research funding.
- Ownership category
- akta.pro rank
BioCrowd industry classification
Industry- Product category
- Biotech Funding Platform
- NAICS
- Grantmaking and Giving Services (81321), Voluntary Health Organizations (813212)
- SIC
- Investment Advice (6282)
- akta.pro primary industry
- Healthcare Access & Life Sciences Impact Funds (FSANAJAI)
- akta.pro secondary industries
- Health & Medical Research Grantmaking Foundations (BPAGAKAL), Capacity Building & Nonprofit Infrastructure Funders (BPAGAKAO)
Keywords
Where BioCrowd is headquartered
LocationHeadquarters
- HQ city
- San Francisco
- HQ country
- United States
- HQ region
- North America
Markets served
BioCrowd business model
Business model- GTM type
- B2B and B2C
- Offering type
- Software
- Cost components
- Technology or R&D, Personnel, Marketing or Sales, Operations, Infrastructure
Revenue model
- Platform/SaaS Fees: R1 and R2 university and hospital research funding SaaS platform with institutional subscriptions for research administration and advancement systems
- Investment Facilitation: Facilitates SAFE-Note based investments and SPV structures linked to research programs, potentially generating transaction or facilitation fees
- Capital Marketplace: Funding marketplace for tech transfer pipeline and research-driven spinouts, connecting capital sources with institutional research opportunities
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Annual | Institutional research funding platform |
Go-to-market motion1 record
Distribution channels3 records
Marketing channels4 records
BioCrowd product offering
Product offeringCore offering
BioCrowd is an institutional research funding SaaS platform that helps hospitals, universities, and patient communities raise milestone-based capital from donors, venture philanthropists, and impact investors. The platform operates as a capital-raising layer between advancement, tech transfer, and research administration systems, releasing capital only after IRB-approved milestones verified via blockchain.
Product overview
BioCrowd is an institutional research funding platform that operates as a SaaS product connecting hospitals, universities, and patient communities with capital sources. The platform consists of three core components: the main BioCrowd Platform serving as the capital marketplace and infrastructure layer, the Research Institution Portal enabling academic and hospital researchers to raise milestone-based capital from donors and impact investors, and the Donor & Investor Portal allowing accredited investors to discover, fund, and track biomedical research investments. The platform specializes in translational research funding, venture philanthropy, and biotech SAFE investments, with capital released only after IRB-approved milestones.
Differentiator
Problem solved
Functional benefit
Products and services
- BioCrowd Platform An institutional research funding SaaS platform that helps hospitals, universities, and patient communities raise milestone-based capital. Serves as a capital-raising layer connecting research institutions with donors, venture philanthropists, and impact investors, with funding released only after IRB-approved milestones.
- Research Institution Portal A portal for academic medical centers, R1/R2 universities, and hospital-based research organizations to raise capital from untapped donor segments, manage project submissions, track milestones with blockchain verification, collaborate with research teams, handle compliance management, and access funding analytics.
- Donor & Investor Portal A portal for accredited investors and donors to discover high-impact biomedical research opportunities, view their investment portfolio dashboard, receive real-time milestone updates, assess investment risks, and measure scientific and social impact of their funding, with options for SAFE-Note/SPV investments or tax-deductible donations.
Quantifiable outcome
- Milestone-based capital release ensures funding is tied to verified research progress
- +1 more outcomes
Companies that use BioCrowd
Customer profileSegments3 records
Ideal customer profiles3 records
BioCrowd technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability2 records
Feature5 records
BioCrowd partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- NASA ISSminorBioCrowd has a dedicated Space section on its platform (accessible via /nasa-iss-partnership URL), suggesting a partnership related to NASA International Space Station research funding. No further details on partnership scope or nature of collaboration provided in available content.
Scale indicators1 record
Recent moves5 records
Expansion highlights5 records
BioCrowd competitors and assessment
Company assessmentDirect peers
- Experiment.com: Crowdfunding platform dedicated to scientific research, allowing researchers to raise funds directly from the public for specific studies. Most directly comparable to BioCrowd in terms of the research-funding marketplace model, though without BioCrowd's milestone-based capital-release and institutional SaaS layer.
- Consano: Nonprofit medical research crowdfunding platform that connects donors with specific research projects and provides impact reporting. Highly comparable as a medical-research-focused funding platform, though operating as a nonprofit rather than a for-profit SaaS/marketplace.
Others
- Wefunder: Large-scale equity crowdfunding platform enabling retail and accredited investors to invest in startups via Regulation Crowdfunding and other structures. Comparable as a regulated investment facilitation platform, though broader in scope and not specialized in research funding.
Broad incumbents
- Republic: Multi-product private investment platform spanning startup equity, crypto, and real estate with significant capital under facilitation. Comparable infrastructure and regulatory expertise for facilitating retail/accredited investments, though not focused on biotech research.
- StartEngine: Equity crowdfunding platform with a large investor base and established compliance infrastructure for SAFE and Regulation Crowdfunding offerings. Operates in the same regulated-investment facilitation space as BioCrowd's investor portal, with much broader deal flow.
- Classy: Leading fundraising platform for nonprofits, serving health and medical charities with donation management, CRM, and campaign tooling. Comparable as institutional-facing fundraising SaaS for research-adjacent organizations, though without investment facilitation or milestone-based capital release.
Emerging players
- Mightycause: Online fundraising platform for nonprofits and personal causes with donor management and campaign tooling. Comparable as a fundraising platform for research-adjacent communities, though narrower in investor-side functionality than BioCrowd.
- Honeycomb Credit: Crowdfunding platform connecting local investors with small businesses via debt offerings, with a regulated investment infrastructure. Comparable in operating a two-sided marketplace with investor-side compliance, though focused on small business lending rather than research funding.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights6 records
Customer concentration
BioCrowd social profiles
Digital presenceBioCrowd financial estimates
Financial estimateRevenue estimate
Valuation estimate
BioCrowd leadership team
Management profileNumber of profiles
BioCrowd funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
BioCrowd M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about BioCrowd
What does BioCrowd do?
BioCrowd is an institutional research funding SaaS platform that helps hospitals, universities, and patient communities raise milestone-based capital from donors, venture philanthropists, and impact investors. The platform operates as a capital-raising layer between advancement, tech transfer, and research administration systems, releasing capital only after IRB-approved milestones verified via blockchain.
Is BioCrowd a public or private company?
BioCrowd is a private company. It is classified as unknown and is currently operating.
When was BioCrowd founded?
BioCrowd was founded in 2022. It employs 1 to 10 people.
Where is BioCrowd based?
BioCrowd is headquartered in San Francisco, United States, in the North America region.
How does BioCrowd make money?
Three revenue lines are on record. Platform/SaaS Fees are the primary driver. The others are investment Facilitation and capital Marketplace.
Who are BioCrowd's main competitors?
Direct peers on record are Experiment.com and Consano. Wefunder is listed as an others. Broad incumbents are Republic, StartEngine and Classy. Emerging players are Mightycause and Honeycomb Credit.
Does BioCrowd have an API?
No public API is recorded for BioCrowd.
What industry is BioCrowd in?
BioCrowd's product category is Biotech Funding Platform. Its primary akta.pro industry code is FSANAJAI, Healthcare Access & Life Sciences Impact Funds, with a secondary code of BPAGAKAL, Health & Medical Research Grantmaking Foundations. Its NAICS code is 81321 and its SIC code is 6282.